Skip to main content

Table 4 Relationship of clinical stage with PGF rs8019391 polymorphism in cervical cancer patients adjusted by age

From: Genetic polymorphisms of PGF and TNFAIP2 genes related to cervical cancer risk among Uygur females from China

SNP ID Model Genotype I-II III-IV OR (95%CI) p
rs8019391 Allele C 110 220 1.00 4.58 × 10−4
T 50 44 2.27 (1.43–3.62)
Codominant CC 37 91 1.00  
CT 36 38 2.34 (1.29–4.25) 0.005
TT 7 3 5.76 (1.41–23.52) 0.015
Dominant CC 37 91 1.00 0.001
CT-TT 43 41 2.59 (1.46–4.60)
Recessive CC-CT 73 129 1.00 0.045
TT 7 3 4.13 (1.04–16.45)
Log-additive 2.36 (1.45–3.86) < 0.001
  1. SNP single nucleotide polymorphism, OR odds ratio, 95% CI 95% confidence interval
  2. p values were calculated by logistic regression analysis with adjustments for age
  3. p < 0.05 indicates statistical significance